The BHP and ABPI wish to enter into a cooperative relationship for the general purpose of exploring activities which seek to further align academic, NHS and industry capabilities, based on shared priorities, for the mutual benefit of all parties and ultimately the wider population.
Erik Nordkamp, Managing Director of Pfizer UK explains why Pfizer has partnered with the Science Museum to sponsor its new exhibition on antibiotic resistance.
The Association of British Pharmaceutical Industry (ABPI) welcomes the strong focus on science and innovation in the Government's green paper on Industrial Strategy, set out today by the Prime Minister. This is further demonstration of their support for research and development which is a...
A new report published today by the Medicines Manufacturing Industry Partnership (MMIP) has asked the Government for support in building four new Centres of Excellence for medicines manufacturing across the UK. The centres would provide high-skilled jobs and make the UK the first place in the world...
Parliamentary Under-Secretary of State at the Department for Business, Energy and Industrial Strategy, Lord Prior of Brampton, has today visited AstraZeneca’s Macclesfield Pharmaceutical Manufacturing Facility.
Dr Maria Groves has been the Head of the Cancer Research UK-MedImmune Alliance Laboratory (CMAL) since its launch. This World Cancer Day, we hear about the areas of cancer research that the industry-academic collaboration is helping to advance, and what she hopes the next 10 years will bring.
A unique partnership announced today by the pharmaceutical industry and Greater Manchester Health and Social Care Partnership will help the city region deliver its vision to be the safest and most effective place to receive medicines in the world – and cement its position on the global research and...
On Tuesday 21 November, Lisa Anson, President of the Association of the British Pharmaceutical Industry (ABPI), gave a speech to the Annual Lunch of the Parliamentary and Scientific Committee.
Following a BBC news story [Wednesday 1 March] reporting that the Hepatitis C Trust took funding from the pharmaceutical industry, the ABPI has responded by highlighting guidance produced in partnership with National Voices, as well as the ABPI Code of Practice.
The investment will allow researchers to investigate innovative new approaches to type 2 diabetes and work together on early stage research.